Pamorelin LA 3.75mg Injection
Active component: Triptorelin
Class of drugs: Gonadotropin-releasing hormone (GnRH) analogs
Uses:
- Prostate cancer in men
- Early onset puberty in children 2 years of age and older (precocious puberty)
Therapeutic effects:
- Suppresses the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) through its action on the pituitary gland
- Decreases the production of sex hormones, such as testosterone and estrogen
- Beneficial in treating hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis
Interaction with other drugs:
- Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products
- Certain medications may interact with Pamorelin LA 3.75mg Injection, reducing effectiveness or causing undesirable side effects
Storage:
- Store at room temperature, between 20°C to 25°C (68°F to 77°F)
- Keep away from moisture, heat, and light
- Do not freeze
- Keep away from children and pets
Administration:
- Typically administered via injection, either subcutaneously (under the skin) or intramuscularly (into the muscle)
- Specific dosing and frequency of administration depend on the individual's condition being treated and their response to the medication
- Follow healthcare professional's instructions regarding the administration technique and schedule
Safety advices:
- Pregnancy: generally not recommended for use during pregnancy
- Breastfeeding: the safety of Pamorelin LA 3.75mg Injection during breastfeeding is not well established
- Lungs: generally considered safe for use in individuals with lung conditions, but consult with a healthcare professional
- Liver: use with caution in individuals with liver impairment or liver disease
- Alcohol: the use of Pamorelin LA 3.75mg Injection in combination with alcohol is not well studied
- Driving: avoid driving or operating machinery if experiencing side effects that impact alertness, concentration, or motor skills
Side effects:
- Serious: swallowing or breathing trouble, increased lymphocyte count in the blood, swelling of lips, tongue or throat
- Common: hot flushes, weakness, excessive sweating, back pain, impotence, nausea, dry mouth, pain, bruising, redness at the injection site, high blood pressure, weight gain, dizziness, headache
FAQs:
Can Pamorelin LA 3.75mg Injection be used to treat infertility? Yes, Pamorelin LA 3.75mg Injection can be used in certain cases to treat infertility. It is sometimes prescribed as part of assisted reproductive technologies.
What is the usual duration of Pamorelin LA 3.75mg Injection treatment? The duration of Pamorelin LA 3.75mg Injection treatment can vary depending on the specific condition being treated.
Can Pamorelin LA 3.75mg Injection be used in children? The safety and effectiveness of Pamorelin LA 3.75mg Injection have not been well established in children. Its use in pediatric patients is generally limited and carefully considered on a case-by-case basis.
Are there any drug interactions associated with Pamorelin LA 3.75mg Injection? Pamorelin LA 3.75mg Injection may interact with certain medications, including hormonal therapies and drugs that affect the function of the pituitary gland.
Can Pamorelin LA 3.75mg Injection cause menopause-like symptoms? Yes, Pamorelin LA 3.75mg Injection can cause menopause-like symptoms such as hot flashes, night sweats, and mood changes.
Fact box:
- Molecule name: Triptorelin
- Therapeutic class: Hormonal therapy
- Pharmacological class: Gonadotropin-releasing hormone (GnRH) analog
- Indications: Prostate cancer, precocious puberty